Amgen’s Tavneos Tied to Deaths, Liver Injury, FDA Says

Amgen Inc.’s drug Tavneos, used to treat a severe form of blood vessel inflammation, has been tied to serious liver injuries and eight deaths, the US Food and Drug Administration said.

There have been 76 cases of drug-induced liver injuries, including 74 with a serious outcome, identified through Oct. 9, 2024, the agency said in a statement Tuesday. In January, the FDA asked Amgen to pull the drug from the market; the company refused.